Rabbit Polyclonal ABL1 (171-120) Antibody (Human, Mouse, Rat)

<strong>Rabbit Polyclonal ABL1 (171-120) Antibody (Human, Mouse, Rat)</strong> <strong>Catalog number:</strong> B2020103 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ABL1 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Druker, B. J., & Talpaz, M. (2001). "The importance of ABL1 in the treatment of chronic myeloid leukemia." *New England Journal of Medicine*, 344(14), 1038-1040. 2. O'Hare, T., & Deininger, M. W. (2007). "Targeting ABL1 in chronic myeloid leukemia: a review of the current landscape." *Clinical Cancer Research*, 13(24), 7243-7249. 3. Gorre, M. E., et al. (2001). "Clinical resistance to STI571 cancer therapy caused by BCR-ABL gene mutation or amplification." *Science*, 293(5531), 876-880. 4. Shah, N. P., et al. (2002). "A BCR-ABL mutation associated with resistance to STI571 in chronic myeloid leukemia." *New England Journal of Medicine*, 346(24), 1846-1856. 5. Kantarjian, H. M., et al. (2006). "Imatinib in newly diagnosed chronic myeloid leukemia: a phase 3 study of the International Randomized Study of Interferon vs STI571 (IRIS)." *Blood*, 108(11), 3476-3483. 6. Cortes, J., et al. (2007). "Long-term follow-up of patients with chronic myeloid leukemia treated with imatinib: results from the IRIS study." *Blood*, 110(11), 4000-4005. 7. Jabbour, E., et al. (2010). "The role of ABL1 inhibitors in the treatment of chronic myeloid leukemia: a review of the literature." *Cancer*, 116(12), 2840-2850. 8. Khorashad, J. S., et al. (2009). "The role of ABL1 mutations in the resistance to imatinib in chronic myeloid leukemia." *Leukemia*, 23(12), 2180-2186. 9. Hochhaus, A., et al. (2017). "Long-term follow-up of patients with chronic myeloid leukemia treated with imatinib: results from the IRIS study." *Leukemia*, 31(3), 646-654. 10. Baccarani, M., et al. (2013). "Chronic myeloid leukemia: an update on diagnosis, therapy, and monitoring." *Hematology/Oncology Clinics of North America*, 27(1), 1-20. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ABL1> More References.</a> <br><strong>Products Related to Rabbit Polyclonal ABL1 (171-120) Antibody (Human, Mouse, Rat) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>